Average Co-Inventor Count = 2.00
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aerpio Pharmaceuticals, Inc. (3 from 8 patents)
2. Eyepoint Pharmaceuticals, Inc. (2 from 20 patents)
3. Aerpio Therapeutics, Inc. (1 from 35 patents)
6 patents:
1. 12145986 - Method of treating an ocular condition by administering a humanized monoclonal antibodies that target VE-PTP (HPTP-Beta)
2. 11180551 - Humanized monoclonal antibodies that target VE-PTP (HPTP-beta)
3. 11136389 - Humanized monoclonal antibodies that target VE-PTP (HPTP-β)
4. 10604569 - Humanized monoclonal antibodies that target protein tyrosine phosphatase-beta (HPTP-β/VE-PTP)
5. 10597452 - Methods of treating ocular conditions by administering humanized monoclonal antibodies that target VE-PTP (HPTP-beta)
6. 10253094 - Antibodies that target human protein tyrosine phosphatase-beta (HPTP-beta) and methods of use thereof to treat ocular conditions